Cardiff Oncology (CRDF) FCF Margin Growth (1y) (2012 - 2025)
Cardiff Oncology (CRDF) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.00 |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 434,378.00 |
| Sep 30, 2025 | -270,636.00 |
| Jun 30, 2025 | -49,610.00 |
| Mar 31, 2025 | -875,050.00 |
| Dec 31, 2024 | -221,793.00 |
| Sep 30, 2024 | -47,030.00 |
| Jun 30, 2024 | 105,779.00 |
| Mar 31, 2024 | 677,814.00 |
| Dec 31, 2023 | 220,843.00 |
| Sep 30, 2023 | 266,452.00 |
| Jun 30, 2023 | 97,963.00 |
| Mar 31, 2023 | 348,831.00 |
| Dec 31, 2022 | -122,894.00 |
| Sep 30, 2022 | -217,653.00 |
| Jun 30, 2022 | -137,500.00 |
| Mar 31, 2022 | -590,886.00 |
| Dec 31, 2021 | -120,712.00 |
| Sep 30, 2021 | -365,686.00 |
| Jun 30, 2021 | 367,965.00 |
| Mar 31, 2021 | -321,046.00 |